{"id":"https://openalex.org/W2016362284","doi":"https://doi.org/10.1016/s1567-5688(07)71096-6","title":"PO3-86 1H NMR METABONOMICS OF SERUM TO IDENTIFY AND CLASSIFY LIPOPROTEIN SUBCLASS PROFILES","display_name":"PO3-86 1H NMR METABONOMICS OF SERUM TO IDENTIFY AND CLASSIFY LIPOPROTEIN SUBCLASS PROFILES","publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W2016362284","doi":"https://doi.org/10.1016/s1567-5688(07)71096-6","mag":"2016362284"},"language":"en","primary_location":{"id":"doi:10.1016/s1567-5688(07)71096-6","doi":"https://doi.org/10.1016/s1567-5688(07)71096-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(07)71096-6","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078073418","display_name":"Mika Ala\u2010Korpela","orcid":"https://orcid.org/0000-0001-5905-1206","observed_orcids":["https://orcid.org/0000-0001-5905-1206"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ala-Korpela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109967644","display_name":"Sanna M. M\u00e4kel\u00e4","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.M. Makela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043596534","display_name":"Aino Salminen","orcid":"https://orcid.org/0000-0001-7576-090X","observed_orcids":["https://orcid.org/0000-0001-7576-090X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Salminen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029295162","display_name":"P. Soininen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Soininen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054878745","display_name":"Teemu Suna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Suna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030702866","display_name":"Niko Lankinen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Lankinen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039595601","display_name":"Petri Ingman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Ingman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113848721","display_name":"M.J. Savolainen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.J. Savolainen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057557099","display_name":"Marja\u2010Riitta Taskinen","orcid":"https://orcid.org/0000-0002-6229-3588","observed_orcids":["https://orcid.org/0000-0002-6229-3588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M-R. Taskinen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030752128","display_name":"Minna L. Hannuksela","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.L. Hannuksela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016356740","display_name":"Matti Jauhiainen","orcid":"https://orcid.org/0000-0002-3836-3785","observed_orcids":["https://orcid.org/0000-0002-3836-3785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Jauhiainen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065692438","display_name":"Kimmo  K. Kaski","orcid":"https://orcid.org/0000-0002-3805-9687","observed_orcids":["https://orcid.org/0000-0002-3805-9687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. Kaski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"1","first_page":"39","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.9243000149726868,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.04639999940991402,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipoprotein-subclasses","display_name":"lipoprotein subclasses","score":0.8420000076293945},{"id":"https://openalex.org/keywords/serum-metabolomics","display_name":"serum metabolomics","score":0.8949999809265137},{"id":"https://openalex.org/keywords/1h-nmr-spectroscopy","display_name":"1H NMR","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lipoprotein-classification","display_name":"lipoprotein classification","score":0.7900000214576721},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.8370000123977661}],"concepts":[{"id":"https://openalex.org/C2776194381","wikidata":"https://www.wikidata.org/wiki/Q3965271","display_name":"Subclass","level":3,"score":0.9776479601860046},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4661860167980194},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4262712299823761},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37362921237945557},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.334988534450531},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15862223505973816},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.14440658688545227},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.07388612627983093}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1567-5688(07)71096-6","doi":"https://doi.org/10.1016/s1567-5688(07)71096-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1567-5688(07)71096-6","pdf_url":null,"source":{"id":"https://openalex.org/S120256695","display_name":"Atherosclerosis Supplements","issn_l":"1567-5688","issn":["1567-5688","1878-5050"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","ki-jl-1","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Atherosclerosis Supplements","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2728229884","https://openalex.org/W2683480049","https://openalex.org/W2611059487","https://openalex.org/W2610773395","https://openalex.org/W1977611029","https://openalex.org/W2725002337","https://openalex.org/W181225814","https://openalex.org/W7043252815","https://openalex.org/W2059635422","https://openalex.org/W2033281781"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}